Safety Study of Pioglitazone Compared To Glyburide on Liver Function
All edits
Edits on 20 Jan, 2024
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Health Conditions in Trial
Interventional Trial Phase
Phase 40
Intervention Treatment
Glyburide0
Pioglitazone0
Intervention Type
Drug0
Masked Party
Care Provider0
Investigator0
Outcomes Assessor0
Participant0
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+156 characters)
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
Article
Study summary
The purpose of this study is to determine the liver safety of pioglitazone, once daily (QD), versus glyburide taken with metformin and insulin.
Infobox
Is a
NCT Number
Trial Recruitment Size
2,1200
Trial Sponsor
Clinical Trial Start Date
2000
0Primary Completion Date
2005
0Study Completion Date
2005
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Official Website
Official Name
A Randomized, Comparator Controlled, Double-Blind Study of the Liver Safety of Pioglitazone HCl vs Glyburide With Metformin and Insulin as Part of Step Therapy in Subjects With Type 2 (Non-Insulin Dependent) Diabetes0
Last Updated
February 28, 2012
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Find more entities like Safety Study of Pioglitazone Compared To Glyburide on Liver Function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.